Sometimes these cards can only be used once or must be used by people with insurance other than Medicare
Both the LEADER (liraglutide) and SUSTAIN-6 (subcutaneous semaglutide) trials reported significant reductions in the primary outcome (incidence of MACE)
Yet LifeVantage promotional materials and distributor pitches tend to spin these results positively
Despite this substantial research history, DSIP has not achieved widespread clinical acceptance or regulatory approval in major markets, reflecting challenges including inconsistent clinical results, unclear mechanisms, difficulty in establishing optimal dosing, route, and timing protocols, and competition from better-characterized sleep and stress medications
Lesions vary in size from a few millimeters to a centimeter
And thanks for sharing this, because I meant to and lost it in distraction yesterday